scispace - formally typeset
K

Karl A. Nath

Researcher at Mayo Clinic

Publications -  289
Citations -  19298

Karl A. Nath is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Kidney & Heme oxygenase. The author has an hindex of 75, co-authored 254 publications receiving 17628 citations. Previous affiliations of Karl A. Nath include University of Minnesota & Wake Forest University.

Papers
More filters
Journal ArticleDOI

Ferritin: a cytoprotective antioxidant strategem of endothelium.

TL;DR: It is concluded that endothelium and perhaps other cell types may be protected from oxidant damage through the iron sequestrant, ferritin.
Journal ArticleDOI

Tubulointerstitial changes as a major determinant in the progression of renal damage.

TL;DR: This report concludes with a review of interstitial fibrosis, a pathologic process regarded as an irreversible outcome from tubulointerstitial injury.
Journal ArticleDOI

Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat

TL;DR: In vivo evidence is provided that induction of heme oxygenase coupled to ferritin synthesis is a rapid, protective antioxidant response, suggesting a therapeutic strategy for populations at a high risk for rhabdomyolysis.
Journal ArticleDOI

Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage.

TL;DR: It is demonstrated that reduced ferrohemoglobin, while relatively innocuous to cultured endothelial cells, when oxidized to ferrihemoglobin (methemoglobin), greatly amplifies oxidant (H2O2)-mediated endothelial-cell injury.
Journal ArticleDOI

Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease

TL;DR: It is concluded that intravascular hemolysis in SCD releases heme that activates endothelial TLR4 signaling leading to WPB degranulation, NF-κB activation, and vaso-occlusion, and heme lethality.